Suppression of host gene expression is associated with latent TB infection: a possible diagnostic biomarker

• Published in: Scientific reports Vol. 14; no. 1; pp. 15621 - 11
• Main Authors: Nakiboneka, Ritah, Margaritella, Nicolò, Nyirenda, Tonney, Chaima, David, Walbaum, Natasha, Musisi, Emmanuel, Tionge, Sikwese, Msosa, Takondwa, Nliwasa, Marriott, Msefula, Chisomo L., Sloan, Derek, Sabiiti, Wilber
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 07.07.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 631/337/2019; 692/53/2421; 692/699/255/1856; Adolescent; Adult; Biomarkers; Biomarkers - blood; Case-Control Studies; Female; Gene expression; Humanities and Social Sciences; Humans; Interferon-gamma Release Tests - methods; Krueppel-like factor; Latent Tuberculosis - blood; Latent Tuberculosis - diagnosis; Latent Tuberculosis - genetics; Male; Middle Aged; multidisciplinary; Science; Science (multidisciplinary); Transcriptome; Transcriptomics; Tuberculosis; Young Adult
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-66486-z

The World Health Organization End TB strategy aims for a 90% reduction of tuberculosis (TB) incidence by 2035. Systematic testing and treatment of latent TB infection (LTBI) among contacts of active TB patients is recommended as one of the ways to curtail TB incidence. However, there is a shortage of tools to accurately diagnose LTBI. We assessed the appropriateness of whole blood host transcriptomic markers (TM) to diagnose LTBI among household contacts of bacteriologically confirmed index cases compared to HIV negative healthy controls (HC). QuantiFERON-TB Gold Plus Interferon gamma release assay (IGRA) and reverse-transcriptase quantitative PCR were used to determine LTBI and quantify TM expression respectively. Association between TM expression and LTBI was evaluated by logistic regression modelling. A total of 100 participants, 49 TB exposed (TBEx) household contacts and 51 HC, were enrolled. Twenty-five (51%) TBEx individuals tested positive by IGRA, and were denoted as LTBI individuals, and 37 (72.5%) HC were IGRA-negative. Expression of 11 evaluated TM was significantly suppressed among LTBI compared to HC. Out of the 11 TM, ZNF296 and KLF2 expression were strongly associated with LTBI and successfully differentiated LTBI from HC. Paradoxically, 21 (49%) TBEx participants who tested IGRA negative exhibited the same pattern of suppressed TM expression as IGRA positive (LTBI-confirmed individuals). Results suggest that suppression of gene expression underlies LTBI and may be a more sensitive diagnostic biomarker than standard-of-care IGRA.